GLP-1 drugs have been a success for public health—and the pharmaceutical companies that make them. But for some of the 13 million Americans taking them, losing muscle along with fat is an unexpected downside that isn’t broadly discussed or immediately apparent.
The Health newsletter takes you inside what’s new in health, medicine and personal well-being. If you’re not subscribed, sign up here.
This Writer Wants Our Obsession With Wrinkles to End
GETTY IMAGES
Since 2002, when Botox was approved for cosmetic use, wrinkles have all but disappeared from our screens—and our personal social media feeds. The writer Emma Rosenblum wonders: What would happen if we all agreed to put down the Botox?
MESSAGE FROM: WSJ | BUY SIDE
Memorial Day Sales
Kick off summer with our editor-approved Memorial Day picks, thoughtfully selected and worth shopping.
How Bodybuilding Helped a Kidnapping Survivor Leave Her Comfort Zone
FOX/GETTY IMAGES
Elizabeth Smart, who made headlines when she was abducted at age 14 and abused by her captors for nine months, is now a competitive bodybuilder. She spoke with WSJ about her physical and mental transformation.
In the News
Popular weight loss drugs may have a surprising side effect: stalling cancer. New studies suggest that drugs such as Ozempic and Zepbound might slow tumor progression and improve survival rates, though more research is needed to confirm the findings.
An Amgen drug got new warnings in Japan after 20 patient deaths. Kissei Pharmaceutical said doctors can again prescribe the rare-disease drug, reversing a recent recommendation that clinicians avoid new prescriptions after recent fatalities.
AstraZeneca said it received U.S. approval for a new hypertension treatment, giving it the green light to launch Baxfendy, a drug brand that the U.K. pharmaceutical company expects to generate multibillion-dollar annual sales at its peak.
• The surgeon general’s office issued a warning on screen time for children. (STAT News)
• Here’s how you should take care of your gut, according to experts. (The Guardian)
• Marathons and ultramarathons may be linked to colon cancer. (The Washington Post)
About Us
The Health newsletter is your weekly guide to all the news that affects your health and well-being. This edition was curated and edited by Conor Grant—send him feedback or questions at conor.grant@wsj.com (if you’re reading this in your inbox, you can just hit reply). Got a tip for us? Here’s how to submit.
Dow Jones & Company, Inc. 4300 U.S. Route 1 North Monmouth Junction, NJ 08852